Investors/Media

Investor Relations

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.